Sleep and Pain in Sickle Cell Disease

Study point of contact

Jennifer Haythornthwaite, PhD
410-550-7000
[email protected]
Claudia Campbell, PhD
410-550-7989
[email protected]

Locations

1 United States site

Age

18 to 100 Years

Genotypes

Hemoglobin SC

Phase

N/A

Study type

Interventional

Gender

All

Interventions

Behavioral

Other

Compensation

Unknown

About the study

This is a study testing the effects of behavioral sleep interventions on pain and brain
function in sickle cell disease.

participation requirements

– Diagnosis of sickle cell hemoglobinopathy (Homozygous sickle cell disease, Hemoglobin
SC disease, or Sickle/beta-thalassemia);

– Adequate facility with English;

– Stable dosing of medications (if taking) for pain and sleep;

– Reports symptoms of insomnia;

– Reports chronic pain

participation restrictions

– Cognitive impairment;

– Unstable psychiatric disorder;

– Seizure disorder;

– Positive pregnancy or drug test

Locations

  • Baltimore, Maryland, United States, Johns Hopkins, 21224 [Recruiting]
Last updated 2021-07-15 Enroll Now